The pathological roles of BART miRNAs in nasopharyngeal carcinoma (Q37995110)

26 August 2017

The pathological roles of BART miRNAs in nasopharyngeal carcinoma (English)

1 reference

26 August 2017

Angela K-F Lo

1

1 reference

26 August 2017

Christopher W Dawson

series ordinal

2

1 reference

26 August 2017

Dong-Yan Jin

series ordinal

3

1 reference

26 August 2017

Kwok-Wai Lo

series ordinal

4

1 reference

26 August 2017

8 May 2012

1 reference

26 August 2017

1 reference

26 August 2017

227

1 reference

26 August 2017

4

1 reference

26 August 2017

392-403

1 reference

Epidemiology of nasopharyngeal carcinoma.

26 August 2017

1 reference

The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma

21 January 2018

1 reference

Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics.

21 January 2018

1 reference

Epstein-Barr virus in the pathogenesis of NPC.

21 January 2018

1 reference

A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci

21 January 2018

1 reference

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

21 January 2018

1 reference

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

21 January 2018

1 reference

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

21 January 2018

1 reference

Focus on nasopharyngeal carcinoma

21 January 2018

1 reference

21 January 2018

Viruses and microRNAs

1 reference

Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus

21 January 2018

1 reference

Epstein-Barr virus BART gene expression.

21 January 2018

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

Identification of virus-encoded microRNAs

21 January 2018

1 reference

Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas

21 January 2018

1 reference

Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22

21 January 2018

1 reference

Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing

21 January 2018

1 reference

Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed

21 January 2018

1 reference

A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses

21 January 2018

1 reference

Modulation of LMP1 protein expression by EBV-encoded microRNAs

21 January 2018

1 reference

Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma

21 January 2018

1 reference

microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma

21 January 2018

1 reference

A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia

21 January 2018

1 reference

Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma.

21 January 2018

1 reference

Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.

21 January 2018

1 reference

Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency

21 January 2018

1 reference

Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells

21 January 2018

1 reference

An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma

21 January 2018

1 reference

Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma

21 January 2018

1 reference

P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas

21 January 2018

1 reference

An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival

21 January 2018

1 reference

The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim.

21 January 2018

1 reference

Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay

21 January 2018

1 reference

TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein Bax.

21 January 2018

1 reference

Mitochondrial targeting of tBid/Bax: a role for the TOM complex?

21 January 2018

1 reference

Epstein-Barr virus: 40 years on

21 January 2018

1 reference

CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients.

21 January 2018

1 reference

CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells

21 January 2018

1 reference

Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients

21 January 2018

1 reference

Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy

21 January 2018

1 reference

Complementary activation of peripheral natural killer cell immunity in nasopharyngeal carcinoma.

21 January 2018

1 reference

Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells.

21 January 2018

1 reference

Modulation of natural killer cell activity by viruses.

21 January 2018

1 reference

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

21 January 2018

1 reference

The importin beta/importin 7 heterodimer is a functional nuclear import receptor for histone H1.

21 January 2018

1 reference

Identification of novel genes that mediate innate immunity using inbred mice

21 January 2018

1 reference

Aire's partners in the molecular control of immunological tolerance

21 January 2018

1 reference

Functional delivery of viral miRNAs via exosomes

21 January 2018

1 reference

Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells.

21 January 2018

1 reference

Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5.

21 January 2018

1 reference

Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma

21 January 2018

1 reference

The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility.

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiation

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway

21 January 2018

1 reference

Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis

21 January 2018

1 reference

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

21 January 2018

1 reference

Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2.

21 January 2018

1 reference

Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma

21 January 2018

1 reference

Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments

21 January 2018

1 reference

Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells

21 January 2018

1 reference

The significance of LMP1 expression in nasopharyngeal carcinoma

21 January 2018

1 reference

The Epstein-Barr virus latent membrane protein 1 (LMP1) enhances TNF alpha-induced apoptosis of intestine 407 epithelial cells: the role of LMP1 C-terminal activation regions 1 and 2.

21 January 2018

1 reference

Latent membrane protein-1 of Epstein-Barr virus inhibits cell growth and induces sensitivity to cisplatin in nasopharyngeal carcinoma cells.

21 January 2018

1 reference

Induction of apoptosis in epithelial cells by Epstein-Barr virus latent membrane protein 1.

21 January 2018

1 reference

Apoptosis modulation of Epstein-Barr virus-encoded latent membrane protein 1 in the epithelial cell line HeLa is stimulus-dependent

21 January 2018

1 reference

Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis.

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells.

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.

21 January 2018

1 reference

Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition

21 January 2018

1 reference

Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas

21 January 2018

1 reference

Exosomes--vesicular carriers for intercellular communication

21 January 2018

1 reference

Exosomes: Fit to deliver small RNA.

21 January 2018

1 reference

Human tumor virus utilizes exosomes for intercellular communication.

21 January 2018

1 reference

Targeting microRNAs in cancer: rationale, strategies and challenges

21 January 2018

1 reference

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

21 January 2018

1 reference

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

21 January 2018

1 reference

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

MicroRNA sponges: progress and possibilities

21 January 2018

1 reference

Utility of Epstein-Barr virus-encoded small RNA promoters for driving the expression of fusion transcripts harboring short hairpin RNAs.

21 January 2018

1 reference

Regulation of expression of the Epstein-Barr virus BamHI-A rightward transcripts.

21 January 2018

1 reference

Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing

21 January 2018

1 reference

The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines.

21 January 2018

1 reference

Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV.

21 January 2018

1 reference

21 January 2018

Epigenetics in cancer

1 reference

Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes

21 January 2018

1 reference

IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency

21 January 2018

1 reference

Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus

21 January 2018

1 reference

Dual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytes

21 January 2018

1 reference

IRF7: activation, regulation, modification and function

21 January 2018

1 reference

Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.

21 January 2018

1 reference

Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas

21 January 2018

1 reference

Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit.

21 January 2018

1 reference

Acetate inhibits NFAT activation in T cellsvia importin β1 interference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.4025

1 reference

26 August 2017

1 reference